return to the Course index
previous | next
a) the drug has a narrow therapeutic-toxic range,
b) there is a large variability in pharmacokinetic parameter values between patients,
c) the therapeutic effect is not readily assessed (e.g. antibiotics) or clinical symptoms are to be avoided (e.g. seizure). Not as useful for blood pressure lowering (can measure B.P. directly) or anticoagulants (again measure clotting time directly),
d) there is a direct relationship between Cp or concentration in other biological sample (e.g. saliva) and pharmacological effect,
e) an appropriate (accurate, short turn around, inexpensive) analytical method is available for the drug,
f) the expected or desired therapeutic effect is not observed (may be absorption or compliance problem),
g) a drug with high first pass effect is involved, or
h) a patients has altered and/or variable renal state and the drug is eliminated mostly as unchanged drug in urine (fe less than 1)
Drug | Therapeutic Concentration Range |
---|---|
Aminoglycoside (gentamicin, tobramycin) | 0.5 <--> 8 mg/L |
Digoxin | 0.5 <--> 2.0 ug/L |
Phenytoin | 10 <--> 20 mg/L |
Theophylline | 10 <--> 20 mg/L |
Information required
Organize sample collection and analysis
Accurate Timing in necessary
Figure 24.2.1 Illustrating the Effect of Sample Times on Parameter Values
Evaluate pharmacokinetically the analytical result and recalculate dosing regimen recommendations
Organize further samples if necessary, repeat as necessary
Material on this website should be used for Educational or Self-Study Purposes Only
Copyright © 2001 - 2025 David W. A. Bourne (david@boomer.org)
![]() | A game to aid in interpreting Prescription Sig instructions See how many Sigs you can catch before you run out of lives |
![]() |